Conversations About Immunotherapy and Caregiving
In this episode, Dr. Ray Liu and Melissa Wilson, PA-C, MPAS, Melanoma Lead at UPMC Hillman Cancer Center, and AIM’s…
Conversations About Immunotherapy and Caregiving
In this episode, Dr. Ray Liu and Melissa Wilson, PA-C, MPAS, Melanoma Lead at UPMC Hillman Cancer Center, and AIM’s…
,
Drawing Strength From Music
…Permanente San Francisco, and host of AIM’s podcast, “Beyond the Clinic: Living Well with Melanoma welcomes music therapist and leader of…
,
2022: The State of Sunscreen in the U.S.
…in Melanoma Research, Professor & Chair, Department of Dermatology, Oregon Health & Science University. Over 197,000 cases of melanoma are…
Survivor Spotlight: Erich & Jenn Djordjevic
…heard about the lesions, Jenn’s mind flashed to 2013, when Erich was diagnosed with Stage IIIB melanoma. He had a…
,
AIM Welcomes Ann Garst Taylor as New Director of Community Engagement
By Mara Klecker Ann Garst Taylor, AIM at Melanoma’s new Director of Community Engagement, has nearly 30 years of volunteer…
,
Things Are About To Get Hairy!
…at Melanoma is proud to have been selected as a 2022 benefitting charity. The “rules” are as simple. You abstain…
How’s it Growing?
AIM at Melanoma is honored to have been selected by the Matthew Hill Foundation to be a benefitting charity in…
,
Shop the Black Ribbon Boutique in May
Since 2020, AIM at Melanoma has partnered with Bonfire.com to sell t-shirts that raise awareness of melanoma as well as…
,
AIM’s Latest Newsletter: The Research Edition, July 2023
This month’s newsletter focuses on the latest news and scientific breakthroughs in melanoma research. This edition features: Letter from AIM’s…
,
FDA Approves First AI-Powered Skin Cancer Diagnostic Tool
…clinical study. January 17, 2024 – original article in Targeted Oncology Sabrina Serani DermaSensor provides quantitative, point-of-testing identification for…
,
,
Recent Posts
Mar. 03, 2026
Cancer is More Than a Diagnosis: Mind, Meaning, and Healing
Feb. 19, 2026
Merlin CP-GEP Becomes the First and Only Gene Expression Profile Test Recommended by NCCN®
Feb. 05, 2026
Best-in-Class Real-World Data Support Early Amtagvi® Treatment in Advanced Melanoma
Jan. 23, 2026
Moderna, Merck’s Skin Cancer Vaccine Shows Sustained Benefit in Five-Year Follow-Up
Jan. 21, 2026